Scanfil Initiates Compulsory Acquisition Proceedings, PartnerTech Files for De-listing


Reading time ( words)

On 25 June 2015, Scanfil Oyj, announced that its public takeover offer to the shareholders in PartnerTech AB was declared unconditional and completed. After completion of the offer, Scanfil holds more tha 90 per cent of the shares and votes in PartnerTech and has notified PartnerTech’s board of directors that Scanfil has resolved to initiate compulsory acquisition proceedings regarding the remaining shares in the Company.

In light of the above, PartnerTech’s board of directors does not consider it reasonable for the Company to remain a listed company, and has therefore decided to apply for de-listing of the PartnerTech share from Nasdaq Stockholm. The last day of trading in the PartnerTech share at Nasdaq Stockholm will be announced as soon as the Company has been notified thereof from Nasdaq Stockholm.

Further, the board of directors has, upon request by Scanfil, decided to summon an extraordinary general meeting to be held on 29 July 2015 to inter alia elect a new board of directors in the Company (see separate press release). 

Share

Print


Suggested Items

Cavity Board SMT Assembly Challenges (Part 2)

07/03/2019 | Dudi Amir and Brett Grossman, Intel Corporation
This article describes the details of a study of assembling SiP BGA packages into a cavity. It points out the challenges involved in the board cavity design and assembly of components in a cavity. The authors discussed the board design challenge of having a cavity and defining the proper depth of the cavity to accommodate the board fabricator, the product design, and the SMT assembly.

3D Optical Inspection Provides ‘Eyes’ for Process Improvements in Industry 4.0

06/21/2019 | Jenny Yuh, Koh Young Technology, and Brent Fischthal, Koh Young America
Automated 3D solder paste inspection (SPI) and 3D automated optical inspection (AOI) systems have become an integral part of the printed circuit board assembly (PCBA) process because they help ensure high-quality production. As today’s board complexity is increasing, inspection technology has become even more critical.

The GraftWorx Fluid Management Patch Story

05/31/2019 | Anthony Flannery, GraftWorx
The GraftWorx vision is to connect patients to clinicians with clinical data that will have a meaningful impact on their care. Its first application is to monitor patients with end-stage renal disease or kidney failure using a wearable device called the SmartPatch that records numerous clinical cardiovascular metrics. This article details how GraftWorx was designed, fabricated, and assembled.



Copyright © 2020 I-Connect007. All rights reserved.